Table 1. Clinical characteristics of patients.

FEATURE	N	%
Age (years)
< 45	37	68.52
≥ 45	17	31.48
Gender
Male	26	48.15
Female	28	51.85
IPS
0-2	35	64.81
≥ 3	19	35.19
Outcome
Refractory	18	33.96
Complete response	35	66.04
Ann Arbor Stage
< IV	36	67.92
≥ IV	17	32.08
Histology
Nodular sclerosis	34	59.64
Mixed cellularity	13	22.8
Lymphocyte-rich	6	10.53
NA	4	7.03
EBV
Positive	15	28.3
Negative	38	71.7